These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34956225)

  • 1. Overlapping but Disparate Inflammatory and Immunosuppressive Responses to SARS-CoV-2 and Bacterial Sepsis: An Immunological Time Course Analysis.
    Loftus TJ; Ungaro R; Dirain M; Efron PA; Mazer MB; Remy KE; Hotchkiss RS; Zhong L; Bacher R; Starostik P; Moldawer LL; Brakenridge SC
    Front Immunol; 2021; 12():792448. PubMed ID: 34956225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons Learned Comparing Immune System Alterations of Bacterial Sepsis and SARS-CoV-2 Sepsis.
    Dong X; Wang C; Liu X; Gao W; Bai X; Li Z
    Front Immunol; 2020; 11():598404. PubMed ID: 33329592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspective of HLA-G Induced Immunosuppression in SARS-CoV-2 Infection.
    Lin A; Yan WH
    Front Immunol; 2021; 12():788769. PubMed ID: 34938296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for Persistent Immune Suppression in Patients Who Develop Chronic Critical Illness After Sepsis.
    Stortz JA; Murphy TJ; Raymond SL; Mira JC; Ungaro R; Dirain ML; Nacionales DC; Loftus TJ; Wang Z; Ozrazgat-Baslanti T; Ghita GL; Brumback BA; Mohr AM; Bihorac A; Efron PA; Moldawer LL; Moore FA; Brakenridge SC
    Shock; 2018 Mar; 49(3):249-258. PubMed ID: 28885387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated frequencies of CD14
    Xue G; Jiang M; Zhao R; Le A; Li J
    Aging (Albany NY); 2021 Feb; 13(5):6236-6246. PubMed ID: 33640878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD14
    Bernsmeier C; Triantafyllou E; Brenig R; Lebosse FJ; Singanayagam A; Patel VC; Pop OT; Khamri W; Nathwani R; Tidswell R; Weston CJ; Adams DH; Thursz MR; Wendon JA; Antoniades CG
    Gut; 2018 Jun; 67(6):1155-1167. PubMed ID: 28592438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Myeloid-derived Suppressor Cells are Associated With Chronic Immune Suppression After Severe Sepsis/Septic Shock.
    Mathias B; Delmas AL; Ozrazgat-Baslanti T; Vanzant EL; Szpila BE; Mohr AM; Moore FA; Brakenridge SC; Brumback BA; Moldawer LL; Efron PA;
    Ann Surg; 2017 Apr; 265(4):827-834. PubMed ID: 27163951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 pneumonia and bacterial pneumonia patients differ in a second hit immune response model.
    Moser D; Feuerecker M; Biere K; Han B; Hoerl M; Schelling G; Kaufmann I; Choukér A; Woehrle T
    Sci Rep; 2022 Sep; 12(1):15485. PubMed ID: 36109525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Adaptive Immune Suppression May Be Why Patients With Severe COVID-19 Cannot Be Discharged From the ICU Even After Negative Viral Tests.
    Zhou Y; Liao X; Song X; He M; Xiao F; Jin X; Xie X; Zhang Z; Wang B; Zhou C; Kang Y; Zhang W
    Front Immunol; 2021; 12():755579. PubMed ID: 34867988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Expansion of Circulating Granulocytic Myeloid-derived Suppressor Cells Predicts Development of Nosocomial Infections in Patients with Sepsis.
    Uhel F; Azzaoui I; Grégoire M; Pangault C; Dulong J; Tadié JM; Gacouin A; Camus C; Cynober L; Fest T; Le Tulzo Y; Roussel M; Tarte K
    Am J Respir Crit Care Med; 2017 Aug; 196(3):315-327. PubMed ID: 28146645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokines, soluble PD-L1, and immune cell hyporesponsiveness are distinct features of SARS-CoV-2 critical illness.
    Morrell ED; Bhatraju PK; Sathe NA; Lawson J; Mabrey L; Holton SE; Presnell SR; Wiedeman A; Acosta-Vega C; Mitchem MA; Liu T; Chai XY; Sahi S; Brager C; Orlov M; Sakr SS; Sader A; Lum DM; Koetje N; Garay A; Barnes E; Cromer G; Bray MK; Pipavath S; Fink SL; Evans L; Long SA; West TE; Wurfel MM; Mikacenic C
    Am J Physiol Lung Cell Mol Physiol; 2022 Jul; 323(1):L14-L26. PubMed ID: 35608267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte activation patterns in hospitalized children: comparing SARS-CoV-2, bacterial infections, and inflammatory pathologies.
    Domitien Payet L; Bedin AS; Desselas É; Marie-Jeanne C; Mollevi C; Malergue F; Bourgoin P; Van de Perre P; Tuaillon É; Jeziorski É
    J Leukoc Biol; 2024 Oct; 116(4):830-837. PubMed ID: 38648502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human leucocyte antigen (HLA-DR) gene expression is reduced in sepsis and correlates with impaired TNFα response: A diagnostic tool for immunosuppression?
    Winkler MS; Rissiek A; Priefler M; Schwedhelm E; Robbe L; Bauer A; Zahrte C; Zoellner C; Kluge S; Nierhaus A
    PLoS One; 2017; 12(8):e0182427. PubMed ID: 28771573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.
    Lafon E; Diem G; Witting C; Zaderer V; Bellmann-Weiler RM; Reindl M; Bauer A; Griesmacher A; Fux V; Hoermann G; Miller C; Zabernigg A; Wöll E; Wilflingseder D; Lass-Flörl C; Posch W
    Front Immunol; 2021; 12():684014. PubMed ID: 34194438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell response against SARS-CoV-2 persists after one year in patients surviving severe COVID-19.
    Venet F; Gossez M; Bidar F; Bodinier M; Coudereau R; Lukaszewicz AC; Tardiveau C; Brengel-Pesce K; Cheynet V; Cazalis MA; Pescarmona R; Garnier L; Ortillon M; Buisson M; Bouscambert-Duchamp M; Morfin-Sherpa F; Casalegno JS; Conti F; Rimmelé T; Argaud L; Cour M; Saadatian-Elahi M; Henaff L; Vanhems P; Monneret G;
    EBioMedicine; 2022 Apr; 78():103967. PubMed ID: 35349827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of monocyte human leukocyte antigen-DR expression and stimulated tumor necrosis factor alpha production as outcome predictors in severe sepsis: a prospective observational study.
    Drewry AM; Ablordeppey EA; Murray ET; Beiter ER; Walton AH; Hall MW; Hotchkiss RS
    Crit Care; 2016 Oct; 20(1):334. PubMed ID: 27760554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of immunosuppressive LOX-1+ PMN-MDSC in septic shock and severe COVID-19 patients with acute respiratory distress syndrome.
    Coudereau R; Waeckel L; Cour M; Rimmele T; Pescarmona R; Fabri A; Jallades L; Yonis H; Gossez M; Lukaszewicz AC; Argaud L; ; Venet F; Monneret G
    J Leukoc Biol; 2022 Feb; 111(2):489-496. PubMed ID: 33909917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with SARS-CoV-2-Induced Viral Sepsis Simultaneously Show Immune Activation, Impaired Immune Function and a Procoagulatory Disease State.
    Limmer A; Engler A; Kattner S; Gregorius J; Pattberg KT; Schulz R; Schwab J; Roth J; Vogl T; Krawczyk A; Witzke O; Zelinskyy G; Dittmer U; Brenner T; Berger MM
    Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.
    Trombetta AC; Farias GB; Gomes AMC; Godinho-Santos A; Rosmaninho P; Conceição CM; Laia J; Santos DF; Almeida ARM; Mota C; Gomes A; Serrano M; Veldhoen M; Sousa AE; Fernandes SM
    Front Immunol; 2021; 12():691725. PubMed ID: 34248984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome.
    Sacchi A; Grassi G; Bordoni V; Lorenzini P; Cimini E; Casetti R; Tartaglia E; Marchioni L; Petrosillo N; Palmieri F; D'Offizi G; Notari S; Tempestilli M; Capobianchi MR; Nicastri E; Maeurer M; Zumla A; Locatelli F; Antinori A; Ippolito G; Agrati C
    Cell Death Dis; 2020 Oct; 11(10):921. PubMed ID: 33110074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.